West Pharmaceutical Services Inc (WST) is a company engaged in the production and distribution of innovative packaging solutions for the global healthcare industry. As a leader in the field, WST has garnered significant attention from investors and analysts alike. One important aspect of assessing the company's potential is through technical analysis, which involves evaluating various indicators and metrics to gauge the stock's performance.

The Relative Strength Index (RSI) is a commonly used technical indicator that measures the speed and change of price movements. With regards to WST stock, the RSI can provide insight into whether the stock is overbought or oversold. A high RSI value suggests that the stock may be overbought and due for a potential price correction, while a low RSI value may indicate the opposite.

West Pharmaceutical Services  (WST) Technical Analysis

A detailed technical analysis of West Pharmaceutical Services Inc (WST) stock, including RSI, ADX, MACD, ROC, STOCHRSI, and WILLR indicators.

West Pharmaceutical Services Inc (WST) Technical Analysis

West Pharmaceutical Services, Inc. designs, manufactures, and sells containment and delivery systems for injectable drugs and healthcare products in the Americas, Europe, the Middle East, Africa, and the Asia Pacific. It operates in two segments, Proprietary Products and Contract-Manufactured Products. The Proprietary Products segment offers stoppers and seals for injectable packaging systems; syringe and cartridge components, including custom solutions for the needs of injectable drug applications, as well as administration systems that enhance the safe delivery of drugs through advanced reconstitution, mixing, and transfer technologies; and films, coatings, washing, and vision inspection and sterilization processes and services to enhance the quality of packaging components. It also provides drug containment solutions, including Crystal Zenith, a cyclic olefin polymer in the form of vials, syringes, and cartridges; and self-injection devices, as well as a range of integrated solutions, including analytical lab services, pre-approval primary packaging support and engineering development, regulatory expertise, and after-sales technical support. This segment serves biologic, generic, and pharmaceutical drug companies. The Contract-Manufactured Products segment is involved in the design, manufacture, and automated assembly of devices used in surgical, diagnostic, ophthalmic, injectable, and other drug delivery systems, as well as consumer products. The company serves pharmaceutical, diagnostic, and medical device companies. It distributes its products through its sales force and distribution network, as well as contract sales agents and regional distributors. The company was incorporated in 1923 and is headquartered in Exton, Pennsylvania.

West Pharmaceutical Services 

NYSE

This suggests that the technical indicators do not strongly favor either a buying or selling stance. In such cases, investors may need to rely on additional fundamental or market analysis to make a well-informed decision.

Balanced or Uncertain

MACD

WILLR

STOCHRSI

Free

is to help users identify stocks that trade at a low value relative to their fundamentals. Suitable for value investors such as Warren Buffet.

Name	Value	Action	infoPnL (10y)
auto_graphRSI	36.62	Neutral	73.8%
auto_graphMACD	17.73	Neutral	499.4%
auto_graphCCI	-105.50	Buy	-16.4%
auto_graphADX	23.65	Neutral	-
auto_graphATR	170.23	Buy	-
auto_graphWILLR	-98.41	Buy	-37.7%
auto_graphROC	-95.82	Neutral	59.0%
auto_graphSTOCHRSI	1.07	Buy	3589.4%

Buy	4	-50.00%
Hold	4	-50.00%
Sell	0	-100.00%

Trendlines, Support and Resistance

Welcome to Stocklytics

Technical Indicators

Indicator Ratings

Balanced or Uncertain

West Pharmaceutical Services (WST) Technical Analysis

Keep an eye on West Pharmaceutical Services

Frequently Asked Questions

What are the technical signals for West Pharmaceutical Services (WST) stock based on the last 30 days?

Take Your Investments to a Whole New Level